Purpose: To evaluate life expectancy and cause of death among patients with Fabry disease, an X-linked lysosomal storage disorder.

Methods: Data from 2848 patients in the Fabry Registry were summarized using descriptive statistics. Life expectancy at birth was compared with that of the United States general population.

Results: As of August 2008, 75 of 1422 males and 12 of 1426 females in the Fabry Registry were reported to have died. The 87 deceased patients were diagnosed at a much older age than other patients in the Fabry Registry: median age at diagnosis was 40 vs. 24 years in males and 55 vs. 33 years in females. The life expectancy of males with Fabry disease was 58.2 years, compared with 74.7 years in the general population of the United States. The life expectancy of females with Fabry disease was 75.4 years, compared with 80.0 years in the United States general population. The most common cause of death among both genders was cardiovascular disease. Most (57%) patients who died of cardiovascular disease had previously received renal replacement therapy.

Conclusions: Most deceased Fabry Registry patients exhibited serious cardiac and renal dysfunction. Late diagnosis may have contributed to the early deaths of these patients.

Download full-text PDF

Source
http://dx.doi.org/10.1097/GIM.0b013e3181bb05bbDOI Listing

Publication Analysis

Top Keywords

life expectancy
20
fabry registry
20
fabry disease
16
females fabry
12
patients fabry
12
united states
12
fabry
9
expectancy death
8
states general
8
years compared
8

Similar Publications

Mental disorders are associated with elevated mortality rates and reduced life expectancy. However, it is unclear whether these associations differ by socioeconomic position (SEP). The aim of this study was to explore comprehensively the role of individual-level SEP in the associations between specific types of mental disorders and mortality (due to all causes, and to natural or external causes), presenting both relative and absolute measures.

View Article and Find Full Text PDF

Effects of population aging on quality of life and disease burden: a population-based study.

Glob Health Res Policy

January 2025

Center for Public Health and Epidemic Preparedness and Response, Peking University, Haidian District, 38Th Xueyuan Road, Beijing, 100191, China.

Background: As population aging intensifies, it becomes increasingly important to elucidate the casual relationship between aging and changes in population health. Therefore, our study proposed to develop a systematic attribution framework to comprehensively evaluate the health impacts of population aging.

Methods: We used health-adjusted life expectancy (HALE) to measure quality of life and disability-adjusted life years (DALY) to quantify the burden of disease for the population of Guangzhou.

View Article and Find Full Text PDF

Background: The worldwide population is ageing and self-arm can be prevented with many techniques. Among them coercive measure consisting of physical restraint (PR) is one of the techniques. This study aims to assess the effects of the biological sex on the long-term survival after PR in geriatric patients during the initial emergency department (ED) visit.

View Article and Find Full Text PDF

Does randomization assert the balance across trial arms? Revisiting Worrall's criticism.

Hist Philos Life Sci

January 2025

Faculty of Philosophy, Institute of Philosophy, Jagiellonian University, Grodzka 52, Kraków, Poland.

We revisit John Worrall's old but still prominent argument against the view that randomization balances the impact of both known and unknown confounders across the treatment and control arms. We argue that his argument involving indefinitely many possible confounders is at odds with statistical theory as it (1) presumes that the purpose of randomized studies is obtaining perfect point estimates for which perfect balance is needed; (2) mistakes equalizing each confounder with the overall (average) impact of all confounders, and (3) assumes that the joint effect of an infinite series of confounders cannot be bounded. We defend the role of randomization in balancing the impact of confounders across the treatment and control arms by putting forward the statistical sense of the balance claim.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!